Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
Ottewell, Penelope D. 1; Lefley, Diane V. 1; Cross, Simon S. 1; Evans, Alyson C. 1; Coleman, Robert E. 1; Holen, Ingunn 1,*
International Journal Of Cancer.
126(2):522-532, January 15, 2010.
(Format: HTML, PDF)